Reply to: "Call of duty: neuro-oncology outpatient management during the COVID-19 pandemic in Milan, Italy"

Denise Bernhardt¹, Stephanie E Combs^{1

2

3}

Affiliations

¹ Department of Radiation Oncology, Technical University of Munich, Rechts der Isar Hospital, Munich, Germany.
² Department of Radiation Sciences, Institute of Radiation Medicine, Neuherberg, Germany.
³ German Consortium for Translational Cancer Research, Partner Site Munich, Munich, Germany.

Comment

Denise Bernhardt et al. Neuro Oncol. 2020.

. 2020 Dec 18;22(12):1893.

doi: 10.1093/neuonc/noaa203.

Denise Bernhardt¹, Stephanie E Combs^{1

2

3}

¹ Department of Radiation Oncology, Technical University of Munich, Rechts der Isar Hospital, Munich, Germany.
² Department of Radiation Sciences, Institute of Radiation Medicine, Neuherberg, Germany.
³ German Consortium for Translational Cancer Research, Partner Site Munich, Munich, Germany.

No abstract available

Comment on

Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV Gliomas.
Bernhardt D, Wick W, Weiss SE, Sahgal A, Lo SS, Suh JH, Chang EL, Foote M, Perry J, Meyer B, Vajkoczy P, Wen PY, Straube C, Pigorsch S, Wilkens JJ, Combs SE. Bernhardt D, et al. Neuro Oncol. 2020 May 5;22(7):928-35. doi: 10.1093/neuonc/noaa113. Online ahead of print. Neuro Oncol. 2020. PMID: 32369601 Free PMC article.
Call of duty: neuro-oncology outpatient management during the COVID-19 pandemic in Milan, Italy.
Borsa S, Bertani G, Gay L, Pirola E, Riva M, Caroli M. Borsa S, et al. Neuro Oncol. 2020 Dec 18;22(12):1891-1892. doi: 10.1093/neuonc/noaa164. Neuro Oncol. 2020. PMID: 32647891 Free PMC article. No abstract available.

1. Borsa S, Bertani G, Gay L, Pirola E, Riva M, Caroli M. Call of duty: neuro-oncology outpatient management during the COVID-19 pandemic in Milan, Italy. Neuro Oncol. 2020. doi: 10.1093/neuonc/noaa164/5869599. - DOI - PMC - PubMed
1. Bernhardt D, Wick W, Weiss SE, et al. Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas. Neuro Oncol. 2020;22:928–935. - PMC - PubMed